Literature DB >> 8453022

Inhibition of acetaminophen and lorazepam glucuronidation in vitro by probenecid.

L L von Moltke1, M Manis, J S Harmatz, R Poorman, D J Greenblatt.   

Abstract

The effect of probenecid on glucuronidation of acetaminophen and lorazepam in hepatic microsomes from various species was studied to see if in vitro results were consistent with previous in vivo observations. Mouse, rat, and human microsomes were incubated with acetaminophen and probenecid while monkey microsomes were incubated with lorazepam and probenecid. Glucuronidation rates in all species varied with substrate, protein, and detergent concentrations. Mice exhibited faster rates of glucuronidation than rats or humans. All species showed inhibition of glucuronidation of acetaminophen or lorazepam when probenecid was added. Analysis suggested competitive inhibition. Thus, in vitro studies support in vivo results and confirm that the inhibition takes place at the hepatic level.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8453022     DOI: 10.1002/bdd.2510140204

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  3 in total

1.  Effects of probenecid and cimetidine on renal disposition of ofloxacin in rats.

Authors:  E F Foote; C E Halstenson
Journal:  Antimicrob Agents Chemother       Date:  1998-02       Impact factor: 5.191

2.  Inhibitory Effects of Selected Antituberculosis Drugs on Common Human Hepatic Cytochrome P450 and UDP-glucuronosyltransferase Enzymes.

Authors:  Lei Cao; David J Greenblatt; Awewura Kwara
Journal:  Drug Metab Dispos       Date:  2017-06-29       Impact factor: 3.922

3.  Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine.

Authors:  L L von Moltke; D J Greenblatt; M M Cotreau-Bibbo; J S Harmatz; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.